🇺🇸 FDA
Pipeline program

ARAVA® 20 mg tablets

B026504

Phase 1 small_molecule completed

Quick answer

ARAVA® 20 mg tablets for Healthy is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials